EIGHTCO HOLDINGS INC. APPOINTS NICOLA CAIANO TO BOARD OF DIRECTORS
Eightco Holdings (NASDAQ: OCTO) has appointed Nicola Caiano to its Board of Directors, replacing Mary Ann Halford who served since October 2021. Caiano brings over 30 years of expertise in financial strategy, capital markets, and investment management.
Currently serving as CFO at Cytometric Therapeutics and Founding Partner of Olea Management , Caiano's experience includes leadership roles at Pinyon Asset Management, Paulson & Co. Inc., J.P. Morgan Chase, and Bear, Stearns & Co. Inc. At Olea Management, he advises family offices and early-stage companies on capital raising and M&A across technology, finance, and consumer goods sectors.
CEO Paul Vassilakos expressed enthusiasm about Caiano's appointment, highlighting his alignment with the company's goals in driving sustainable growth and shareholder value, particularly in technology and inventory funding sectors.
Eightco Holdings (NASDAQ: OCTO) ha nominato Nicola Caiano nel suo Consiglio di Amministrazione, sostituendo Mary Ann Halford, che ricopriva il ruolo da ottobre 2021. Caiano vanta oltre 30 anni di esperienza in strategia finanziaria, mercati dei capitali e gestione degli investimenti.
Attualmente CFO di Cytometric Therapeutics e socio fondatore di Olea Management, Caiano ha ricoperto ruoli di leadership presso Pinyon Asset Management, Paulson & Co. Inc., J.P. Morgan Chase e Bear, Stearns & Co. Inc. In Olea Management, consiglia family office e aziende in fase iniziale su raccolta fondi e fusioni e acquisizioni nei settori tecnologico, finanziario e dei beni di consumo.
Il CEO Paul Vassilakos ha espresso entusiasmo per la nomina di Caiano, sottolineando la sua sintonia con gli obiettivi aziendali di promuovere una crescita sostenibile e valore per gli azionisti, in particolare nei settori della tecnologia e del finanziamento delle scorte.
Eightco Holdings (NASDAQ: OCTO) ha nombrado a Nicola Caiano en su Junta Directiva, reemplazando a Mary Ann Halford, quien ocupó el cargo desde octubre de 2021. Caiano aporta más de 30 años de experiencia en estrategia financiera, mercados de capital y gestión de inversiones.
Actualmente es CFO en Cytometric Therapeutics y socio fundador de Olea Management. Su experiencia incluye cargos de liderazgo en Pinyon Asset Management, Paulson & Co. Inc., J.P. Morgan Chase y Bear, Stearns & Co. Inc. En Olea Management, asesora a oficinas familiares y empresas en etapa inicial sobre captación de capital y fusiones y adquisiciones en los sectores de tecnología, finanzas y bienes de consumo.
El CEO Paul Vassilakos expresó entusiasmo por el nombramiento de Caiano, destacando su alineación con los objetivos de la compañía para impulsar un crecimiento sostenible y valor para los accionistas, especialmente en los sectores de tecnología y financiamiento de inventarios.
Eightco Holdings (NASDAQ: OCTO)는 Nicola Caiano를 이사회에 임명했으며, 2021년 10월부터 재직한 Mary Ann Halford를 대신합니다. Caiano는 금융 전략, 자본 시장 및 투자 관리 분야에서 30년 이상의 경험을 보유하고 있습니다.
현재 Cytometric Therapeutics의 CFO이자 Olea Management의 창립 파트너인 Caiano는 Pinyon Asset Management, Paulson & Co. Inc., J.P. Morgan Chase, Bear, Stearns & Co. Inc. 등에서 리더십 역할을 수행했습니다. Olea Management에서는 기술, 금융 및 소비재 분야의 가족 사무소와 초기 단계 기업에 자본 조달 및 인수합병 자문을 제공합니다.
CEO Paul Vassilakos는 Caiano의 임명에 대해 큰 기대를 표하며, 특히 기술 및 재고 자금 조달 분야에서 지속 가능한 성장과 주주 가치를 추진하는 회사의 목표와 잘 부합한다고 강조했습니다.
Eightco Holdings (NASDAQ : OCTO) a nommé Nicola Caiano au sein de son conseil d'administration, en remplacement de Mary Ann Halford, en poste depuis octobre 2021. Caiano apporte plus de 30 ans d'expertise en stratégie financière, marchés des capitaux et gestion d'investissements.
Actuellement directeur financier chez Cytometric Therapeutics et associé fondateur d'Olea Management, Caiano a occupé des postes de direction chez Pinyon Asset Management, Paulson & Co. Inc., J.P. Morgan Chase et Bear, Stearns & Co. Inc. Chez Olea Management, il conseille des family offices et des entreprises en phase de démarrage sur la levée de fonds et les fusions-acquisitions dans les secteurs de la technologie, de la finance et des biens de consommation.
Le PDG Paul Vassilakos s’est dit enthousiaste à propos de la nomination de Caiano, soulignant son alignement avec les objectifs de l’entreprise visant à stimuler une croissance durable et la création de valeur pour les actionnaires, notamment dans les secteurs de la technologie et du financement des stocks.
Eightco Holdings (NASDAQ: OCTO) hat Nicola Caiano in den Vorstand berufen und ersetzt damit Mary Ann Halford, die seit Oktober 2021 im Amt war. Caiano bringt über 30 Jahre Erfahrung in Finanzstrategie, Kapitalmärkten und Investmentmanagement mit.
Derzeit ist er CFO bei Cytometric Therapeutics und Gründungspartner von Olea Management. Caiano hatte Führungspositionen bei Pinyon Asset Management, Paulson & Co. Inc., J.P. Morgan Chase und Bear, Stearns & Co. Inc. inne. Bei Olea Management berät er Family Offices und Start-ups bei Kapitalbeschaffung und M&A in den Bereichen Technologie, Finanzen und Konsumgüter.
CEO Paul Vassilakos zeigte sich begeistert von Caianos Ernennung und hob hervor, dass dieser hervorragend zu den Unternehmenszielen passt, nachhaltiges Wachstum und Aktionärswert vor allem in den Bereichen Technologie und Lagerfinanzierung voranzutreiben.
- Appointment of board member with extensive financial strategy and capital markets expertise
- New director brings valuable experience in capital raising and M&A advisory
- Strategic addition to support company's growth in technology and inventory funding sectors
- Loss of board continuity with departure of long-serving director Mary Ann Halford
Easton, PA, April 28, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”) today announced the appointment of Nicola Caiano to its Board of Directors. Mr. Caiano brings over three decades of expertise in financial strategy, capital markets, and investment management, further strengthening Eightco’s strategic vision and growth trajectory.
Mr. Caiano currently serves as Chief Financial Officer at Cytometric Therapeutics, where he leads capital formation strategies to fund clinical trials for groundbreaking cancer therapies. He is also the Founding Partner of Olea Management LLC, where he advises family offices and early-stage companies across diverse industries, including technology, finance, and consumer goods, on capital raising and mergers and acquisitions. Previously, Mr. Caiano was a Partner and Director of Research at Pinyon Asset Management, managing a global event-driven equity and credit portfolio. His career also includes senior roles at Paulson & Co. Inc., J.P. Morgan Chase, and Bear, Stearns & Co. Inc.
“We are thrilled to welcome Nicola Caiano to our Board of Directors,” said Paul Vassilakos, CEO and Chairman of Eightco. “Nic’s proven track record in financial strategy, capital raising, and investment management aligns with our goals to drive sustainable growth and shareholder value. We look forward to him utilizing his expertise and strategic vision to help us execute our ambitious plans to lead in the technology and inventory funding sectors.”
Mr. Caiano is replacing Mary Ann Halford. Ms. Halford had served on Eightco’s Board since October 2021. “We would like to thank Mary Ann for her dedicated service. Her insights, commitment, and leadership have made a lasting impact. We deeply appreciate her contributions and wish her all the best in her current and future endeavours,” said Mr. Vassilakos.
About Eightco Holdings, Inc. Eightco (NASDAQ: OCTO) is committed to growth of its subsidiary, Forever 8 Fund, LLC, an inventory capital and management platform for e-commerce sellers. In addition, the Company is actively seeking new opportunities to add to its portfolio of technology solutions focused on the e-commerce ecosystem through strategic acquisitions. Through a combination of innovative strategies and focused execution, Eightco aims to create significant value and growth for its stockholders.
For additional information, please visit www.8co.holdings and www.forever8.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this press release other than statements of historical fact could be deemed forward looking. Words such as “plans,” “expects,” “will,” “anticipates,” “continue,” “expand,” “advance,” “develop” “believes,” “guidance,” “target,” “may,” “remain,” “project,” “outlook,” “intend,” “estimate,” “could,” “should,” and other words and terms of similar meaning and expression are intended to identify forward-looking statements, although not all forward-looking statements contain such terms. Forward-looking statements are based on management’s current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: Eightco’s ability to maintain compliance with the Nasdaq’s continued listing requirements; unexpected costs, charges or expenses that reduce Eightco’s capital resources; Eightco’s inability to raise adequate capital to fund its business; and Eightco’s inability to innovate and attract users for Eightco’s products and services. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Eightco’s actual results to differ from those contained in forward-looking statements, see Eightco’s filings with the SEC, including in its Annual Report on Form 10-K filed with the SEC on April 15, 2025. All information in this press release is as of the date of the release, and Eightco undertakes no duty to update this information or to publicly announce the results of any revisions to any of such statements to reflect future events or developments, except as required by law.
For further information, please contact:
Investor Relations
investors@8co.holdings
FAQ
What experience does Nicola Caiano bring to Eightco Holdings (OCTO) board?
Who did Nicola Caiano replace on Eightco Holdings (OCTO) board?
What is Nicola Caiano's current role outside of Eightco Holdings (OCTO)?
How will Nicola Caiano's appointment impact Eightco Holdings (OCTO) strategy?
